FIELD: medicine; ophthalmology.
SUBSTANCE: to achieve the effect, a composition including at least one non-nucleotide or non-albumen agent inhibiting expression of connective tissue growth factor (CTGF) is introduced.
EFFECT: new class of medicines for the listed diseases.
2 ex, 4 dwg
Authors
Dates
2008-08-27—Published
2003-04-18—Filed